Equity Overview
Price & Market Data
Price: $2.26
Daily Change: +$0.13 / 5.75%
Daily Range: $0 - $0
Market Cap: $118,345,152
Daily Volume: 0
Performance Metrics
1 Week: 1.43%
1 Month: 87.68%
3 Months: 168.9%
6 Months: 118.2%
1 Year: 90.18%
YTD: 54.35%
Company Details
Employees: 62
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.